正电子发射断层扫描（PET）成像在乳腺癌中的应用。
PET Imaging for Breast Cancer.
机构信息
Breast Imaging and Intervention Section, Department of Radiology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792-3252, USA; Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, 1111 Highland Avenue, Madison, WI 53705, USA; University of Wisconsin Carbone Cancer Center, 600 Highland Avenue, Madison, WI 53792, USA.
University of Wisconsin Carbone Cancer Center, 600 Highland Avenue, Madison, WI 53792, USA; Nuclear Medicine and Molecular Imaging Section, Department of Radiology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792-3252, USA.
出版信息
Radiol Clin North Am. 2021 Sep;59(5):725-735. doi: 10.1016/j.rcl.2021.05.004.
Imaging plays an integral role in the clinical care of patients with breast cancer. This review article focuses on the use of PET imaging for breast cancer, highlighting the clinical indications and limitations of 2-deoxy-2-[F]fluoro-d-glucose (FDG) PET/CT, the potential use of PET/MRI, and 16α-[F]fluoroestradiol (FES), a newly approved radiopharmaceutical for estrogen receptor imaging.
成像在乳腺癌患者的临床护理中起着不可或缺的作用。本文重点介绍了正电子发射断层扫描（PET）成像在乳腺癌中的应用，强调了 2-脱氧-2-[F]氟代-D-葡萄糖（FDG）PET/CT 的临床适应证和局限性、正电子发射断层扫描/磁共振成像（PET/MRI）的潜在应用以及 16α-[F]氟雌二醇（FES）——一种新批准的用于雌激素受体成像的放射性药物。
Zotero 插件